University of Crete (UOC)
Διερεύνηση της έκφρασης στον πλακούντα των γονιδίων της πλακουντιακής αυξητικής ορμόνης (hPGH), του ινσουλινοειδούς αυξητικού παράγοντα-ένα (IGF-1) και των δεσμευτικών αυτού πρωτεϊνών ένα (IGFBP-1) και τρία (IGFBP-3) στην προεκλαμψία και την υπολειπόμενη ενδομήτρια ανάπτυξη
Abstract
dc:descriptionIntroduction: The pathophysiologic mechanisms leading to deterioration of intrauterine growth are poorly understood. hPGH and a variety of growth factors are implicated in normal fetal development. hPGH is the primary (and from midgestation and beyond the unique) growth hormone in human gestation. It is an essential mitogen leading to cell proliferation differentiation and finally organ formation. It also promotes oxygen glucose nutrient and substrate transfer from the mother to the fetus across the placenta. Most of the actions of hPGH are exercised indirectly through regulation of IGF-1 activity hPGH and IGF-1 form an endocrine axis that controls fetal growth and enables maternal metabolism adjust to gestation in favor of the fetus. Aim of study: To evaluate the expression of hPGH, IGF-1, IGFBP-1 and IGFBP-3 genes in placentas from human pregnancies complicated by IUGR. Materials and methods: Our study group comprised of term placentas from 47 IUGR pregnancies not related with preeclampsia chromosomal anomalies or intrauterine infections of the fetus. As control group we used 37 placentas from pregnancies that resulted in the birth of healthy singleton children with birth weight appropriate for gestational age and gender qRT-PCR was applied for the evaluation of the genes expression status. The expression status of the genes of interest was compared with 8 already published databases. Results: The mRNA expression levels of the genes hPGH, IGF-1 and IGFBP-1 were significantly lower vs the controls (p=0.003 p=0.049 and p=0.001 respectively). The mRNA expression levels of IGFBP-3 gene were also lower compared to controls however the difference was not statistically significant. All the genes of interest exhibited significant co-expression patterns both in IUGR (p<0.01) and control (p<0.05) pregnancies. Conclusion: We demonstrated hPGH and IGF-1 mRNA down-regulation in IUGR associated placentas. Whether these findings are the cause of the deterioration of growth in utero or whether they accompany other pathogenetic mechanisms of IUGR requires further investigation.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κουτσάκη, Μαρία
- Koutsaki, Maria
Subjects
dc:subject × 20- Εμβρυϊκή ανάπτυξη
- Πλακουντιακή έκφραση
- Πλακουντιακή αυξητική ορμόνη
- Ινσουλινοειδής αυξητικός παράγοντας-1 (IGF-1)
- IGF δεσμευτική πρωτεΐνη 1
- IGF δεσμαυτική πρωτεΐνη 3
- Ενδομήτρια υπολειπόμενη ανάπτυξη
- Προεκλαμψία
- Fetal growth
- Placental expression
- Human placental growth hormone
- Insulin-line growth factor I, IGF-I
- IGF binding protein 1
- IGF binding protein 3
- Fetal growth restriction
- Preeclampsia
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24900